“Life is short.”
In order to improve the quality of life and be happy, you must be free from disease.
‘Health’ is the biggest issue in an aging society.
The United Nations has set 2021 to 2030 as 10 years for 'healthy aging'.
Major diseases that threaten human health aging
One of the causes of (cardiovascular disease, cerebrovascular disease, dementia, peripheral vascular disease, etc.)
This is because as HDL decreases, blood vessels narrow and become blocked.
When the amount and function of HDL decrease around the age of 20,
Cholesterol builds up in the inner lining of the blood vessels, causing them to narrow quickly.
When blood vessels are blocked by more than 70%
Along with symptoms such as high blood pressure, headache, blurred vision, chest tightness, and cold hands and feet
It causes diseases that threaten health.
"Longevity Factor HDL Symposium" is an international symposium organized by YTN science and sponsored by RAYDEL.
This symposium explores various ways to increase the amount and function of longevity factor HDL,
It aims to prevent and improve disease.
Therefore, we gathered HDL researchers who are making excellent achievements around the world in one place.
Through HDL, we want to find ways to improve human health and quality of life together.
In order to improve the quality of life and be happy, you must be free from disease.
‘Health’ is the biggest issue in an aging society.
The United Nations has set 2021 to 2030 as 10 years for 'healthy aging'.
Major diseases that threaten human health aging
One of the causes of (cardiovascular disease, cerebrovascular disease, dementia, peripheral vascular disease, etc.)
This is because as HDL decreases, blood vessels narrow and become blocked.
When the amount and function of HDL decrease around the age of 20,
Cholesterol builds up in the inner lining of the blood vessels, causing them to narrow quickly.
When blood vessels are blocked by more than 70%
Along with symptoms such as high blood pressure, headache, blurred vision, chest tightness, and cold hands and feet
It causes diseases that threaten health.
"Longevity Factor HDL Symposium" is an international symposium organized by YTN science and sponsored by RAYDEL.
This symposium explores various ways to increase the amount and function of longevity factor HDL,
It aims to prevent and improve disease.
Therefore, we gathered HDL researchers who are making excellent achievements around the world in one place.
Through HDL, we want to find ways to improve human health and quality of life together.
“Life is short.”
In order to improve the quality of life and be happy, you must be free from disease.
‘Health’ is the biggest issue in an aging society.
The United Nations has set 2021 to 2030 as 10 years for 'healthy aging'.
Major diseases that threaten human health aging
One of the causes of (cardiovascular disease, cerebrovascular disease, dementia, peripheral vascular disease, etc.)
This is because as HDL decreases, blood vessels narrow and become blocked.
When the amount and function of HDL decrease around the age of 20,
Cholesterol builds up in the inner lining of the blood vessels, causing them to narrow quickly.
When blood vessels are blocked by more than 70%
Along with symptoms such as high blood pressure, headache, blurred vision, chest tightness, and cold hands and feet
It causes diseases that threaten health.
"Longevity Factor HDL Symposium" is an international symposium organized by YTN science and sponsored by RAYDEL.
This symposium explores various ways to increase the amount and function of longevity factor HDL,
It aims to prevent and improve disease.
Therefore, we gathered HDL researchers who are making excellent achievements around the world in one place.
Through HDL, we want to find ways to improve human health and quality of life together.
In order to improve the quality of life and be happy, you must be free from disease.
‘Health’ is the biggest issue in an aging society.
The United Nations has set 2021 to 2030 as 10 years for 'healthy aging'.
Major diseases that threaten human health aging
One of the causes of (cardiovascular disease, cerebrovascular disease, dementia, peripheral vascular disease, etc.)
This is because as HDL decreases, blood vessels narrow and become blocked.
When the amount and function of HDL decrease around the age of 20,
Cholesterol builds up in the inner lining of the blood vessels, causing them to narrow quickly.
When blood vessels are blocked by more than 70%
Along with symptoms such as high blood pressure, headache, blurred vision, chest tightness, and cold hands and feet
It causes diseases that threaten health.
"Longevity Factor HDL Symposium" is an international symposium organized by YTN science and sponsored by RAYDEL.
This symposium explores various ways to increase the amount and function of longevity factor HDL,
It aims to prevent and improve disease.
Therefore, we gathered HDL researchers who are making excellent achievements around the world in one place.
Through HDL, we want to find ways to improve human health and quality of life together.
The Speakers
- Anand Rohatgi, M.D.
- Professor of Medicine, University of Texas Southwestern Medical Center, Division of Cardiology (US)
- UT Southwestern Medical Center, M.D., Clinical Science
- Associate Program Director of Cardiovascular Fellowship
- ‘Texas Loves Children’ Chairman, Board of Directors
- Lancet, JAMA, AHA, etc., Reviewer of multiple journals
- Specialists of the American College of Cardiology and American Heart Association
- Anna Schwendeman, Ph.D.
- Professor of Pharmaceutical Sciences, University of Michigan(US)
- University of Michigan, Research Assistant Professor, Department of Medicinal Chemistry College of Pharmacy
- William I Higuchi Collegiate Professor of Pharmacy
- Co-Director of Center for Research in Complex Generics
- Co-Founder and VP of Product Development, EVOQ Therapeutics
- Theodoros Kelesidis, Ph.D.
- Associate Professor, Department of Medicine, Division of Infectious Diseases, UT Southwestern Medical Center (US)
- University of California, Clinical and Translational Research, M.Sc.,
- Greece, Attikon University Hospital, University of Athens Medical School Research Fellow, Fourth Academic Department of Internal Medicine and Infectious Diseases
- Massachusetts General Hospital, Harvard Medical School, Research Fellow, Division of Infectious Diseases,
- Francesca Zimetti, Ph.D.
- Associate Professor of Pharmacology, Department of Food and Drugs, University of Parma (ITA)
- University of Parma, Ph.D. in Experimental Pharmacology and Toxicology
- University of Parma, Research Assistant Professor of Pharmacology, Department of Food and Drug
- Children’s Hospital of Philadelphia Research Institute, research fellowship in pharmacology, laboratory of lipid metabolism.
- Sarahi Mendoza Castaño, Ph.D.
- Director of Research, Development and Innovation. National Center for Scientific Research(CUB)
- Ph.D., University of Havana, Pharmaceutical Sciences
- Head of the Quality Assurance Unit at the Center of Natural Products of the National Center for Scientific Research
- Head of the Quality Assurance Unit of Laboratorios Dalmer, SA.
- Head of Centre of Natural Products, National Centre for Scientific Research.
- Javier Vicente Sánchez López, Dr., Ph.D.
- President of the national commission on cerebrovascular diseases, National Institute of Neurology and Neurosciences(CUB)
- Pablo de Olavide University, Master in Neurology and Biology of the Behaviour
- Ph.D., University of Havana, Neurology, Intensive Care and Emergencies.
- Neurology specialist of the Institute of Neurology and Neurosurgery
- Head of the intensive care unit of the Institute of Neurology and Neurosurgery for 20 years
- Training course of cerebrovascular and neurological diseases in Spanish hospitals La Paz and Gregorio Marañon
- Yoshinari UEHARA, M.D., Ph.D.
- Professor, Department of Cardiology, Fukuoka University Hospital (JPN)
- Fukuoka University, Department of Internal Medicine, Ph.D
- Fukuoka University Hospital, Department of Neurology & Healthcare
- Fukuoka University Hospital, Professor, Department of Cardiology, Associate professor
- Fukuoka University, Dean, Faculty of Sports and Health Science
- Kyung Hyun Cho, Ph.D.
- Head of RAYDEL Research Institute (KOR)
- Kyungpook National Univ. Dept.Genetic Eng. Biochemistry, B.S.
- Cleveland Clinic Foundation/Lerner Research Institute, Dept. of Cell Biology, Research doctor.
- Korea Research Institute of Bioscience and Biotechnology, Lab of Lipid Metabolism & Atherosclerosis, Senior research scientist
- Yeungnam University, Dept of Medical Biotechnology, Full professor
The Speakers
-
- Anand Rohatgi, M.D.
- Professor of Medicine, University of Texas Southwestern Medical Center, Division of Cardiology (US)
- UT Southwestern Medical Center, M.D., Clinical Science
- Associate Program Director of Cardiovascular Fellowship
- ‘Texas Loves Children’ Chairman, Board of Directors
- Lancet, JAMA, AHA, etc., Reviewer of multiple journals
- Specialists of the American College of Cardiology and American Heart Association
-
- Anna Schwendeman, Ph.D.
- Professor of Pharmaceutical Sciences, University of Michigan(US)
- University of Michigan, Research Assistant Professor, Department of Medicinal Chemistry College of Pharmacy
- William I Higuchi Collegiate Professor of Pharmacy
- Co-Director of Center for Research in Complex Generics
- Co-Founder and VP of Product Development, EVOQ Therapeutics
-
- Theodoros Kelesidis, Ph.D.
- Associate Professor, Department of Medicine, Division of Infectious Diseases, UT Southwestern Medical Center (US)
- University of California, Clinical and Translational Research, M.Sc.,
- Greece, Attikon University Hospital, University of Athens Medical School Research Fellow, Fourth Academic Department of Internal Medicine and Infectious Diseases
- Massachusetts General Hospital, Harvard Medical School, Research Fellow, Division of Infectious Diseases,
-
- Francesca Zimetti, Ph.D.
- Associate Professor of Pharmacology, Department of Food and Drugs, University of Parma (ITA)
- University of Parma, Ph.D. in Experimental Pharmacology and Toxicology
- University of Parma, Research Assistant Professor of Pharmacology, Department of Food and Drug
- Children’s Hospital of Philadelphia Research Institute, research fellowship in pharmacology, laboratory of lipid metabolism.
-
- Sarahi Mendoza Castaño, Ph.D.
- Director of Research, Development and Innovation. National Center for Scientific Research(CUB)
- Ph.D., University of Havana, Pharmaceutical Sciences
- Head of the Quality Assurance Unit at the Center of Natural Products of the National Center for Scientific Research
- Head of the Quality Assurance Unit of Laboratorios Dalmer, SA.
- Head of Centre of Natural Products, National Centre for Scientific Research.
-
- Javier Vicente Sánchez López, Dr., Ph.D.
- President of the national commission on cerebrovascular diseases, National Institute of Neurology and Neurosciences(CUB)
- Pablo de Olavide University, Master in Neurology and Biology of the Behaviour
- Ph.D., University of Havana, Neurology, Intensive Care and Emergencies.
- Neurology specialist of the Institute of Neurology and Neurosurgery
- Head of the intensive care unit of the Institute of Neurology and Neurosurgery for 20 years
- Training course of cerebrovascular and neurological diseases in Spanish hospitals La Paz and Gregorio Marañon
-
- Yoshinari UEHARA, M.D., Ph.D.
- Professor, Department of Cardiology, Fukuoka University Hospital (JPN)
- Fukuoka University, Department of Internal Medicine, Ph.D
- Fukuoka University Hospital, Department of Neurology & Healthcare
- Fukuoka University Hospital, Professor, Department of Cardiology, Associate professor
- Fukuoka University, Dean, Faculty of Sports and Health Science
-
- Kyung Hyun Cho, Ph.D.
- Head of RAYDEL Research Institute (KOR)
- Kyungpook National Univ. Dept.Genetic Eng. Biochemistry, B.S.
- Cleveland Clinic Foundation/Lerner Research Institute, Dept. of Cell Biology, Research doctor.
- Korea Research Institute of Bioscience and Biotechnology, Lab of Lipid Metabolism & Atherosclerosis, Senior research scientist
- Yeungnam University, Dept of Medical Biotechnology, Full professor
